BeiGene Ltd. ADR (BGNE) Social Stream



BeiGene Ltd. ADR (BGNE): $219.71

0.69 (+0.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BGNE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 382

in industry

BEIGENE LTD (BGNE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BEIGENE LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $431 $343.3 $403.716 $219.02 84.33%
2022-01-06 6 $431 $283.3 $392.46 $219.02 79.19%
2022-01-12 6 $431 $283.3 $388.716 $219.02 77.48%
2022-01-18 6 $431 $283.3 $380.883 $219.02 73.9%
2022-01-28 6 $431 $283.3 $367.55 $219.02 67.82%
2022-02-08 6 $431 $283.3 $354.216 $219.02 61.73%
2022-02-25 6 $431 $283.3 $348.55 $219.02 59.14%
2022-02-28 6 $431 $254 $332.333 $219.02 51.74%
2022-03-17 6 $431 $177 $300.2 $219.02 37.07%
2022-04-28 6 $431 $177 $313.166 $219.02 42.99%
2022-05-06 6 $431 $177 $296.166 $219.02 35.22%
2022-05-18 6 $431 $177 $289.833 $219.02 32.33%
2022-07-27 6 $431 $177 $288.666 $219.02 31.8%
2022-08-05 6 $431 $177 $284.316 $219.02 29.81%
2022-08-09 6 $431 $177 $271.983 $219.02 24.18%
2022-09-17 6 $431 $177 $270.6 $219.02 23.55%
2022-10-03 6 $431 $177 $269.433 $219.02 23.02%
2022-10-13 6 $296 $200 $236.433 $219.02 7.95%
2022-11-14 6 $296 $205 $240.266 $219.02 9.7%
2022-12-12 7 $296 $205 $244.6 $219.02 11.68%
2022-12-15 6 $302 $205 $245.6 $219.02 12.14%
2023-01-19 6 $302 $205 $256.266 $219.02 17.01%
2023-01-24 6 $325 $205 $261.266 $219.02 19.29%
2023-02-07 7 $325 $205 $261.266 $219.02 19.29%
2023-02-20 7 $325 $205 $266.316 $219.02 21.59%
2023-02-28 7 $321 $205 $261.85 $219.02 19.56%
2023-03-01 7 $350 $230.1 $293.35 $219.02 33.94%

The Trend in the Analyst Price Target


BGNE's average price target has moved up $103.12 over the prior 33 months.

Over the past 46 weeks, BGNE's average upside potential has been 45.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-28 6 431 177.0 313.166 158.45 97.64%
2022-05-09 6 431 177.0 289.833 134.22 115.94%
2022-07-27 6 431 177.0 288.666 177.61 62.53%
2023-01-19 6 302 205.0 256.266 274.50 -6.64%
2023-02-28 7 350 230.1 294.183 224.63 30.96%

BGNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


BGNE's average broker recommendation rating improved by 0.54 over the prior 52 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how BEIGENE LTD fares relative to all US stocks, note that its average analyst price target is higher than 3309.74% of that group.
  • BEIGENE LTD's number of analysts covering the stock is greater than 315.93% of stocks in the large market cap category.
  • BEIGENE LTD's upside potential (average analyst target price relative to current price) is higher than 693.98% of Pharmaceutical Products stocks.
  • In terms of how BEIGENE LTD fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1142.27% of that group.

Stocks similar to BEIGENE LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GSK, GRFS, and SNY.

Is BGNE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6625 seconds.